Nutrition and Coronary Heart Disease
The behavioural stage is concerned with the intervention’s success in altering the
actions of an individual or group. For example, how successful is an “eat less fat”
advertising campaign in changing peoples’ consumption of fatty foods? In other words,
it is a measure of the intervention’s success at making people modify their behaviour in
the ‘real’ world, as opposed to the clinical setting of most trials.
The clinical and biomedical stages, on the other hand, are concerned with the scientific
impact of the interventions. The behaviour modification is taken as a given and the
impact on risk factors and the objective (i.e. deaths due to CHD) are examined. The
clinical stage considers the effect the intervention will have on the risk factor being
modified. For example, if an individual eats less salt, by how much will his/her blood
pressure be lowered? The biomedical question posed is how successful is the lowering
of blood pressure in preventing CHD?
CHERE Project Report 11 - November 1999
36
More intriguing information
1. Concerns for Equity and the Optimal Co-Payments for Publicly Provided Health Care2. Ongoing Emergence: A Core Concept in Epigenetic Robotics
3. The name is absent
4. The Tangible Contribution of R&D Spending Foreign-Owned Plants to a Host Region: a Plant Level Study of the Irish Manufacturing Sector (1980-1996)
5. Non-farm businesses local economic integration level: the case of six Portuguese small and medium-sized Markettowns• - a sector approach
6. Cultural Diversity and Human Rights: a propos of a minority educational reform
7. The technological mediation of mathematics and its learning
8. Neighborhood Effects, Public Housing and Unemployment in France
9. Can genetic algorithms explain experimental anomalies? An application to common property resources
10. Assessing Economic Complexity with Input-Output Based Measures